Peri Implant Marginal Bone Height and Bone Density
Peri Implant Marginal Bone Height and Density Supporting Different Prosthesis Restoring Single Edentulous Mandible
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
In this study 10 patients will be selected following inclusion and exclusion criteria. In each group 5 patients (each patient will receive 6 implants) will be divided randomly into two groups.
Group I patients will receive mandibular implant supported removable overdenture, while Group II will receive mandibular implant supported fixed overdenture.
All patients will be given the usual home care instructions about wearing and caring of dentures and opposing arch. Regarding dentures, removal of them at night and cleaning with denture brush and mild soap will be required. Measurements of Bone height and Bone density will be obtained by using Cone Beam Computed Tomography (CBCT).
Measurements will be obtained at denture insertion, after 1 month and after 3 months.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 12622
- National Research Centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Non-smoker Patients
- Highly cooperative and motivated patients.
- Patients Systemically free from any immunosuppressive diseases.
Exclusion Criteria:
- Diabetic, hypertensive, cancer patients.
- Mandibular arch with thin knife edge, flat or flabby ridge, recent extractions and foreign bodies.
- Patients with temporo-mandibular joint disorders and bad oral habits.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: group 1
patients received mandibular implant supported removable overdenture
|
bone height was measured at 1 ,30 ,90 days after denture insertion
|
|
Active Comparator: group 2
patients received mandibular implant supported fixed overdenture
|
bone height was measured at 1 ,30 ,90 days after denture insertion
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
assessment of change of bone height around dental implants
Time Frame: on the first day, on 30th day, 90th day
|
bone height was assessed by cone beam computed tomography
|
on the first day, on 30th day, 90th day
|
|
assessment of change of bone density around dental implants
Time Frame: on the first day, on 30th day, 90th day
|
bone density was assessed by cone beam computed tomography
|
on the first day, on 30th day, 90th day
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Menatallah Elhotieby, Researcher, National Research Centre, Egypt
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 1431022023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.